|
1
|
Goffin V, Binart N, Touraine P and Kelly
PA: Prolactin: The new biology of an old hormone. Annu Rev Physiol.
64:47–67. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reber PM: Prolactin and immunomodulation.
Am J Med. 95:637–644. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Freeman ME, Kanyicska B, Lerant A and Nagy
G: Prolactin: Structure, function, and regulation of secretion.
Physiol Rev. 80:1523–631. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Athreya BH, Pletcher J, Zulian F, Weiner
DB and Williams WV: Subset-specific effects of sex hormones and
pituitary gonadotropins on human lymphocyte proliferation in vitro.
Clin Immunol Immunopathol. 66:201–211. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matera L, Mori M and Galetto A: Galetto,
Effect of prolactin on the antigen presenting function of
monocyte-derived dendritic cells. Lupus. 10:728–734. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lahat N, Miller A, Shtiller R and Touby E:
Differential effects of prolactin upon activation and
differentiation of human B lymphocytes. J Neuroimmunol. 47:35–40.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ben-Jonathan N, Mershon JL, Allen DL and
Steinmetz RW: Extrapituitary prolactin: Distribution, regulation,
functions, and clinical aspects. Endocr Rev. 17:639–669. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Bellis A, Bizzarro A, Pivonello R,
Lombardi G and Bellastella A: Prolactin and autoimmunity.
Pituitary. 8:25–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sodhi A and Tripathi A: Prolactin and
growth hormone induce differential cytokine and chemokine profile
in murine peritoneal macrophages in vitro: Involvement of p-38 MAP
kinase, STAT3 and NF-kappaB. Cytokine. 41:162–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tripathi A and Sodhi A: Prolactin-induced
production of cytokines in macrophages in vitro involves JAK/STAT
and JNK MAPK pathways. Int Immunol. 20:327–336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corbacho AM, Macotela Y, Nava G, Eiserich
JP, Cross CE, Martínez de la Escalera G and Clapp C: Cytokine
induction of prolactin receptors mediates prolactin inhibition of
nitric oxide synthesis in pulmonary fibroblasts. FEBS Lett.
544:171–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jara LJ, Vera-Lastra O, Miranda JM, Alcala
M and Alvarez-Nemegyei J: Prolactin in human systemic lupus
erythematosus. Lupus. 10:748–756. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chikanza IC, Petrou P, Chrousos G,
Kingsley G and Panayi GS: Excessive and dysregulated secretion of
prolactin in rheumatoid arthritis: Immunopathogenetic and
therapeutic implications. Br J Rheumatol. 32:445–448. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El Miedany YM, Ahmed I, Moustafa H and El
Baddini M: Hyperprolactinemia in Sjogren's syndrome: A patient
subset or a disease manifestation? Joint Bone Spine. 71:203–208.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chikanza IC: Prolactin and
neuroimmunomodulation: in vitro and in vivo observations. Ann NY
Acad Sci. 876:119–130. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nicoletti F, Di Marco R, Barcellini W,
Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P
and Meroni P: Protection from experimental autoimmune diabetes in
the non-obese diabetic mouse with soluble interleukin-1 receptor.
Eur J Immunol. 24:1843–1847. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nicoletti F, Zaccone P, Di Marco R,
Lunetta M, Magro G, Grasso S, Meroni P and Garotta G: Prevention of
spontaneous autoimmune diabetes in diabetes-prone BB rats by
prophylactic treatment with antirat interferon-gamma antibody.
Endocrinology. 138:281–288. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joosten LA, Helsen MM, van de Loo FA and
van den Berg WB: Anticytokine treatment of established type II
collagen-induced arthritis in DBA/1 mice: A comparative study using
anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. Arthritis Rheum.
58:S110–S122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sinha YN: Structural variants of
prolactin: Occurrence and physiological significance. Endocr Rev.
16:354–369. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sinha YN: Prolactin variants. Trends
Endocrinol Metab. 3:100–106. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Champier J, Claustrat B, Sassolas G and
Berger M: Detection and enzymatic deglycosylation of a glycosylated
variant of prolactin in human plasma. FEBS Lett. 212:220–224. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
González-Lucano LR, Muñoz-Valle JF,
Ascencio-Cedillo R, Domínguez-Rosales JA, López-Rincón G, Del
Toro-Arreola S, Bueno-Topete M, Daneri-Navarro A, Estrada-Chávez C
and Pereira-Suárez AL: Increased expression of the prolactin
receptor is associated with malignant laryngeal tumors. Exp Ther
Med. 3:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lopez-Pulido EI, Muñoz-Valle JF, Del
Toro-Arreola S, Jave-Suárez LF, Bueno-Topete MR, Estrada-Chávez C
and Pereira-Suárez AL: High expression of prolactin receptor is
associated with cell survival in cervical cancer cells. Cancer Cell
Int. 13:1032013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
López-Rincón G, Pereira-Suárez AL, Del
Toro-Arreola S, Sánchez-Hernández PE, Ochoa-Zarzosa A, Muñoz-Valle
JF and Estrada-Chávez C: Lipopolysaccharide induces the expression
of an autocrine prolactin loop enhancing inflammatory response in
monocytes. J Inflamm. 10:242013. View Article : Google Scholar
|
|
25
|
Larrea F, Martínez-Castillo A, Cabrera V,
Alcocer-Varela J, Queipo G, Cariño C and Alarcón-Segovia D: A
bioactive 60-kilodalton prolactin species is preferentially
secreted in cultures of mitogen-stimulated and nonstimulated
peripheral blood mononuclear cells from subjects with systemic
lupus erythematosus. J Clin Endocrinol Metab. 82:3664–3669. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goffin V, Binart N, Clément-Lacroix P,
Bouchard B, Bole-Feysot C, Edery M, Lucas BK, Touraine P, Pezet A,
Maaskant R, et al: From the molecular biology of prolactin and its
receptor to the lessons learned from knockout mice models. Genet
Anal. 15:189–201. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schindler C: Cytokines and JAK-STAT
signaling. Exp Cell Res. 253:7–14. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Das R and Vonderhaar BK: Involvement of
SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary
epithelial cells. Oncogene. 13:1139–1145. 1996.PubMed/NCBI
|
|
29
|
Domínguez-Cáceres MA, García-Martínez JM,
Calcabrini A, González L, Porque PG, León J and Martín-Pérez J:
Prolactin induces c-Myc expression and cell survival through
activation of Src/Akt pathway in lymphoid cells. Oncogene.
23:7378–7390. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berlanga JJ, Gualillo O, Buteau H,
Applanat M, Kelly PA and Edery M: Prolactin activates tyrosyl
phosphorylation of insulin receptor substrate 1 and
phosphatidylinositol-3-OH kinase. J Biol Chem. 272:2050–2052. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramírez de Arellano A, Lopez-Pulido EI,
Martínez-Neri PA, Estrada Chávez C, González Lucano R,
Fafutis-Morris M, Aguilar-Lemarroy A, Muñoz-Valle JF and
Pereira-Suárez AL: STAT3 activation is required for the
antiapoptotic effects of prolactin in cervical cancer cells. Cancer
Cell Int. 15:832015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
López-Rincón G, Mancilla R, Pereira-Suárez
AL, Martínez-Neri PA, Ochoa-Zarzosa A, Muñoz-Valle JF and
Estrada-Chávez C: Expression of autocrine prolactin and the short
isoform of prolactin receptor are associated with inflammatory
response and apoptosis in monocytes stimulated with Mycobacterium
bovis proteins. Exp Mol Pathol. 98:517–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yonezawa T, Chen KH, Ghosh MK, Rivera L,
Dill R, Ma L, Villa PA, Kawaminami M and Walker AM: Anti-metastatic
outcome of isoform-specific prolactin receptor targeting in breast
cancer. Cancer Lett. 366:84–92. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neradugomma NK, Subramaniam D, Tawfsik OW,
Goffin V, Kumar TR, Jensen RA and Anant S: Prolactin signaling
enhances colon cancer stemness by modulating Notch signaling in a
Jak2-STAT3/ERK manner. Carcinogenesis. 35:795–806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goffin V, Hoang DT, Bogorad RL and
Nevalainen MT: Prolactin regulation of the prostate gland: A female
player in a male game. Nat Rev Urol. 8:597–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Robertson FG, Harris J, Naylor MJ, Oakes
SR, Kindblom J, Dillner K, Wennbo H, Törnell J, Kelly PA, Green J
and Ormandy CJ: Prostate development and carcinogenesis in
prolactin receptor knockout mice. Endocrinology. 144:3196–3205.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clevenger CV, Furth PA, Hankinson SE and
Schuler LA: The role of prolactin in mammary carcinoma. Endocr Rev.
24:1–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tworoger SS and Hankinson SE: Prolactin
and breast cancer etiology: An epidemiologic perspective. J Mammary
Gland Biol Neoplasia. 13:41–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ascencio-Cedillo R, López-Pulido EI,
Muñoz-Valle JF, Villegas-Sepúlveda N, Del Toro-Arreola S,
Estrada-Chávez C, Daneri-Navarro A, Franco-Topete R, Pérez-Montiel
D, García-Carrancá A and Pereira-Suárez AL: Prolactin and prolactin
receptor expression in cervical intraepithelial neoplasia and
cancer. Pathol Oncol Res. 21:241–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gout PW, Beer CT and Noble RL:
Prolactin-stimulated growth of cell cultures established from
malignant Nb rat lymphomas. Cancer Res. 40:2433–2436.
1980.PubMed/NCBI
|
|
42
|
Noble RL, Beer CT and Gout PW: Evidence in
vivo and in vitro of a role for the pituitary in the growth of
malignant lymphomas in Nb rats. Cancer Res. 40:2437–2440.
1980.PubMed/NCBI
|
|
43
|
Perks CM, Keith AJ, Goodhew KL, Savage PB,
Winters ZE and Holly JM: Prolactin acts as a potent survival factor
for human breast cancer cell lines. Br J Cancer. 91:305–311. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Giuffrida D, Perdichizzi A, Giuffrida MC,
La Vignera S, D'Agata R, Vicari E and Calogero AE: Does prolactin
induce apoptosis? Evidences in a prostate cancer in vitro model. J
Endocrinol Invest. 33:313–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Asai-Sato M, Nagashima Y, Miyagi E, Sato
K, Ohta I, Vonderhaar BK and Hirahara F: Prolactin inhibits
apoptosis of ovarian carcinoma cells induced by serum starvation or
cisplatin treatment. Int J Cancer. 115:539–544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shoupe D, Montz FJ, Kletzky OA and
DiZerega GS: Prolactin molecular heterogeneity. Response to
thyrotropin-releasing hormone stimulation of concanavalin A-bound
and -unbound immunoassayable prolactin during human pregnancy. Am J
Obstet Gynecol. 147:482–487. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qin HR, Kim HJ, Kim JY, Hurt EM, Klarmann
GJ, Kawasaki BT, Duhagon Serrat MA and Farrar WL: Activation of
signal transducer and activator of transcription 3 through a
phosphomimetic serine 727 promotes prostate tumorigenesis
independent of tyrosine 705 phosphorylation. Cancer Res.
68:7736–7741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Clevenger CV: Roles and regulation of stat
family transcription factors in human breast cancer. Am J Pathol.
165:1449–1460. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ling X and Arlinghaus RB: Knockdown of
STAT3 expression by RNA interference inhibits the induction of
breast tumors in immunocompetent mice. Cancer Res. 65:2532–2536.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chan KS, Sano S, Kiguchi K, Anders J,
Komazawa N, Takeda J and DiGiovanni J: Disruption of Stat3 reveals
a critical role in both the initiation and the promotion stages of
epithelial carcinogenesis. J Clin Invest. 114:720–728. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pedranzini L, Leitch A and Bromberg J:
Stat3 is required for the development of skin cancer. J Clin
Invest. 114:619–622. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Alvarez JV, Mukherjee N, Chakravarti A,
Robe P, Zhai G, Chakladar A, Loeffler J, Black P and Frank DA: A
STAT3 gene expression signature in gliomas is associated with a
poor prognosis. Transl Oncogenomics. 2:99–105. 2007.PubMed/NCBI
|
|
53
|
Abou-Ghazal M, Yang DS, Qiao W,
Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W,
Sawaya R and Heimberger AB: The incidence, correlation with
tumor-infiltrating inflammation, and prognosis of phosphorylated
STAT3 expression in human gliomas. Clin Cancer Res. 14:8228–8235.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shukla S, Mahata S, Shishodia G, Pandey A,
Tyagi A, Vishnoi K, Basir SF, Das BC and Bharti AC: Functional
regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
PLoS One. 8:e678492013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang Z, Mao H, Du X, Zhu J, Xu Y, Wang S,
Xu X, Ji P, Yu Y, Cao B, et al: A novel small molecule agent
displays potent anti-myeloma activity by inhibiting the JAK2-STAT3
signaling pathway. Oncotarget. 7:9296–9308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang S, An W, Yao Y, Chen R, Zheng X, Yang
W, Zhao Y, Hu X, Jiang E, Bie Y, et al: Interleukin 37 expression
inhibits STAT3 to suppress the proliferation and invasion of human
cervical cancer cells. J Cancer. 6:962–969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Eichhorn JM, Alford SE, Sakurikar N and
Chambers TC: Molecular analysis of functional redundancy among
anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.
Exp Cell Res. 322:415–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chao DT, Linette GP, Boise LH, White LS,
Thompson CB and Korsmeyer SJ: Bcl-XL and Bcl-2 repress a common
pathway of cell death. J Exp Med. 182:821–828. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Villunger A, Scott C, Bouillet P and
Strasser A: Essential role for the BH3-only protein Bim but
redundant roles for Bax, Bcl-2, and Bcl-w in the control of
granulocyte survival. Blood. 101:2393–2400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Paradkar PH, Joshi JV, Mertia PN, Agashe
SV and Vaidya RA: Role of cytokines in genesis, progression and
prognosis of cervical cancer. Asian Pac J Cancer Prev.
15:3851–3864. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Goncalves MA and Donadi EA: Immune
cellular response to HPV: Current concepts. Braz J Infect Dis.
8:1–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
